Stock UniverseDerived research view · source repositories remain read-only

Avanos Medical, Inc. (AVNS)

Life Science Tools / Diagnostics / MedTech · Healthcare / Medical Devices
Score Band
Speculative
Selection Score
28.10
Global Rank
2310
Market Cap
655.70M
Latest Close
25.05
RS Composite
73.19% · G#75

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
1.33%
3M
88.49%
6M
121.49%
1Y
100.88%
3Y
2.24%
5Y
-37.53%
10Y
-19.43%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 725.92K · 30-day average: 1.39M · Max drawdown over stored range: -86.39%

Research Snapshot

Relative Strength vs SPX

RS Composite73.19%
20D RS0.49%
60D RS77.97%
120D RS104.75%
Global RS Rank75 · 97.76% percentile
Watch+Speculative RS Rank40 · 98.09% percentile
Group ScopeWatch+Speculative
Primary RS Rank1 · 99.30% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank111 / 246
Primary Percentile55.28
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for AVNS.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue714.8587684.1673.3687.8701.2
Revenue Growth (YoY)2.466%-17.879%16.542%-1.579%2.154%1.948%
Gross Profit370.9299.2394.2379.7381.3353.9
Operating Income4.44.135.542.444.815.5
Free Cash Flow-22.766.371.614.682.943.1
Free Cash Flow Per Share-0.4751.3641.5140.3131.8020.931
EPS (Diluted) GAAP-0.610.1309771.076759-1.32618-8.526086-1.574514
EPS Growth10800%10800%722.098%10800%10800%
EPS Non-GAAP
Gross Margin51.889%50.971%57.623%56.394%55.438%50.471%
Operating Margin0.616%0.698%5.189%6.297%6.514%2.21%
Profit Margin-4.057%1.073%7.382%-9.179%-57.008%-10.396%
Free Cash Flow Margin-3.176%11.295%10.466%2.168%12.053%6.147%
Shares Outstanding (Diluted)47.848.647.346.64646.3
Shares Change (YoY)0.42%1.674%-2.675%-1.48%-1.288%0.652%

SEC Quarterly Fundamentals

No processed quarterly rows for AVNS.